Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

Table 1 Stakeholder groups and the numbers invited, registered to attend, attending the events and responding to the event evaluation survey

Stakeholder group	Invited	Registered (%)	Attended (% of those registered)	Responded to evaluation survey (% of those attending)
Trial participants^a	438	79 (18)	53 (67)	30 (56)
Breast Cancer Now (BCN) coaches	45	22 (49)	21 (95)	12 (57)
NHS staff^b	12	8 (67)	8 (100)	3 (38)
Leisure Centre staff	8	2 (25)	2 (100)	1 (50)
BCN staff	5	5 (100)	4 (80)	0
Public representatives	5	1 (20)	1 (100)	1 (100)
Funder staff	2	0	0	0
Trial team	3	0	0	0
Total	519	117 (23)	89	47

^aAll participants within ActWell who are alive, have not withdrawn, have not left Scotland and have the status “Completed Study”
^bTwelve NHS staff members were invited directly (investigators and their team) while staff at breast cancer screening centres were sent invitations via a generic email address and the number of recipients is therefore unknown

ISSN: 1745-6215